Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Co-Diagnostics Stock Surges on Ebola Assay News — The Fine Print Is Big

Co-Diagnostics Stock Surges on Ebola Assay News — The Fine Print Is Big

Co-Diagnostics Inc. shares jumped in heavy U.S. trading on Tuesday after the molecular diagnostics company said it had completed a strategy for a possible Ebola assay tied to the Bundibugyo virus outbreak in the Democratic Republic of Congo and Uganda. The stock was recently up 51% at $2.07, after touching $2.73, on volume above 94 million shares; the iShares Russell 2000 exchange-traded fund, a small-cap stock basket, was down about 1.2%.
InMed Soars 100% on $290M Migraine Deal

InMed Soars 100% on $290M Migraine Deal

InMed Pharmaceuticals shares jumped over 100% in busy Nasdaq trading Tuesday. The Vancouver drug developer said it will merge with private Mentari Therapeutics in an all-stock deal, aiming to bring the public company into migraine prevention therapies.
19 May 2026
Dow Jones Falls as Bond Yields Signal Trouble for Bulls

Dow Jones Falls as Bond Yields Signal Trouble for Bulls

Dow drops as yields, oil push stocks down The Dow Jones Industrial Average lost ground Tuesday morning, down 249.36 points, or 0.5%, to 49,436.76 by 10:55 a.m. EDT. Treasury yields moved higher and concerns about oil-driven inflation grew, dragging Wall Street lower. S&P 500 declined 0.77%. Nasdaq Composite was off 1.28%, with selling pressure showing up outside of the Dow’s 30 stocks.
XRP’s $10 Bet Just Ran Into a $1.37 Problem

XRP’s $10 Bet Just Ran Into a $1.37 Problem

XRP traded near $1.37 on Tuesday as new forecasts sharpened a split over the token: one camp still sees a staged path toward $4 and beyond, while skeptics say Ripple’s own payments strategy could weaken XRP’s role. Recent articles from 24/7 Wall St., The Motley Fool and TipRanks put that divide back in front of investors within a softening crypto market.
19 May 2026
1 61 62 63 64 65 890
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY

Pfizer

NYSE: PFE 93 / 100
#2 TACTICAL BUY

AMD

NASDAQ: AMD 91 / 100
#3 STRONG BUY

AerCap

NYSE: AER 90 / 100
#4 BUY ONLY ON PULLBACK

Booking Holdings

NASDAQ: BKNG 88 / 100
#5 BUY ON WEAKNESS

Visa

NYSE: V 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.